97 related articles for article (PubMed ID: 12204106)
1. Independence of plasma membrane blebbing from other biochemical and biological characteristics of apoptotic cells.
Shiratsuchi A; Mori T; Nakanishi Y
J Biochem; 2002 Sep; 132(3):381-6. PubMed ID: 12204106
[TBL] [Abstract][Full Text] [Related]
2. Rho kinase regulates fragmentation and phagocytosis of apoptotic cells.
Orlando KA; Stone NL; Pittman RN
Exp Cell Res; 2006 Jan; 312(1):5-15. PubMed ID: 16259978
[TBL] [Abstract][Full Text] [Related]
3. Rho kinase regulates phagocytosis, surface expression of GlcNAc, and Golgi fragmentation of apoptotic PC12 cells.
Orlando KA; Pittman RN
Exp Cell Res; 2006 Oct; 312(17):3298-311. PubMed ID: 16904666
[TBL] [Abstract][Full Text] [Related]
4. The nucleotide receptor P2X7 mediates actin reorganization and membrane blebbing in RAW 264.7 macrophages via p38 MAP kinase and Rho.
Pfeiffer ZA; Aga M; Prabhu U; Watters JJ; Hall DJ; Bertics PJ
J Leukoc Biol; 2004 Jun; 75(6):1173-82. PubMed ID: 15075366
[TBL] [Abstract][Full Text] [Related]
5. Active relocation of chromatin and endoplasmic reticulum into blebs in late apoptotic cells.
Lane JD; Allan VJ; Woodman PG
J Cell Sci; 2005 Sep; 118(Pt 17):4059-71. PubMed ID: 16129889
[TBL] [Abstract][Full Text] [Related]
6. Rho-kinase (ROCK-1 and ROCK-2) upregulation in oleic acid-induced lung injury and its restoration by Y-27632.
Köksel O; Yildirim C; Tiftik RN; Kubat H; Tamer L; Cinel L; Kaplan MB; Değirmenci U; Ozdülger A; Büyükafşar K
Eur J Pharmacol; 2005 Mar; 510(1-2):135-42. PubMed ID: 15740734
[TBL] [Abstract][Full Text] [Related]
7. Apoptotic and necrotic blebs in epithelial cells display similar neck diameters but different kinase dependency.
Barros LF; Kanaseki T; Sabirov R; Morishima S; Castro J; Bittner CX; Maeno E; Ando-Akatsuka Y; Okada Y
Cell Death Differ; 2003 Jun; 10(6):687-97. PubMed ID: 12761577
[TBL] [Abstract][Full Text] [Related]
8. Ouabain-induced apoptosis and Rho kinase: a novel caspase-2 cleavage site and fragment of Rock-2.
Ark M; Ozdemir A; Polat B
Apoptosis; 2010 Dec; 15(12):1494-506. PubMed ID: 20661774
[TBL] [Abstract][Full Text] [Related]
9. Rho/ROCK pathway as a target of tumor therapy.
Rattan R; Giri S; Singh AK; Singh I
J Neurosci Res; 2006 Feb; 83(2):243-55. PubMed ID: 16385577
[TBL] [Abstract][Full Text] [Related]
10. Rho kinase inhibition initiates apoptosis in human airway epithelial cells.
Moore M; Marroquin BA; Gugliotta W; Tse R; White SR
Am J Respir Cell Mol Biol; 2004 Mar; 30(3):379-87. PubMed ID: 12933355
[TBL] [Abstract][Full Text] [Related]
11. Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I.
Coleman ML; Sahai EA; Yeo M; Bosch M; Dewar A; Olson MF
Nat Cell Biol; 2001 Apr; 3(4):339-45. PubMed ID: 11283606
[TBL] [Abstract][Full Text] [Related]
12. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing.
Sebbagh M; Renvoizé C; Hamelin J; Riché N; Bertoglio J; Bréard J
Nat Cell Biol; 2001 Apr; 3(4):346-52. PubMed ID: 11283607
[TBL] [Abstract][Full Text] [Related]
13. Y-27632, an inhibitor of Rho-associated kinases, prevents tyrosine phosphorylation of focal adhesion kinase and paxillin induced by bombesin: dissociation from tyrosine phosphorylation of p130(CAS).
Sinnett-Smith J; Lunn JA; Leopoldt D; Rozengurt E
Exp Cell Res; 2001 Jun; 266(2):292-302. PubMed ID: 11399057
[TBL] [Abstract][Full Text] [Related]
14. ROCK-II-induced membrane blebbing and chromatin condensation require actin cytoskeleton.
Song Y; Hoang BQ; Chang DD
Exp Cell Res; 2002 Aug; 278(1):45-52. PubMed ID: 12126956
[TBL] [Abstract][Full Text] [Related]
15. Modulation of aqueous humor outflow facility by the Rho kinase-specific inhibitor Y-27632.
Rao PV; Deng PF; Kumar J; Epstein DL
Invest Ophthalmol Vis Sci; 2001 Apr; 42(5):1029-37. PubMed ID: 11274082
[TBL] [Abstract][Full Text] [Related]
16. Effects of rho-associated protein kinase inhibitor Y-27632 on intraocular pressure and outflow facility.
Honjo M; Tanihara H; Inatani M; Kido N; Sawamura T; Yue BY; Narumiya S; Honda Y
Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):137-44. PubMed ID: 11133858
[TBL] [Abstract][Full Text] [Related]
17. Enhancement of cisplatin-induced cytotoxicity by ROCK inhibitor through suppression of focal adhesion kinase-independent mechanism in lung carcinoma cells.
Igishi T; Mikami M; Murakami K; Matsumoto S; Shigeoka Y; Nakanishi H; Yasuda K; Gutkind JS; Hitsuda Y; Shimizu E
Int J Oncol; 2003 Oct; 23(4):1079-85. PubMed ID: 12963988
[TBL] [Abstract][Full Text] [Related]
18. Rho-kinase inhibitor, Y-27632, has an antinociceptive effect in mice.
Büyükafşar K; Yalçin I; Kurt AH; Tiftik RN; Sahan-Firat S; Aksu F
Eur J Pharmacol; 2006 Jul; 541(1-2):49-52. PubMed ID: 16750189
[TBL] [Abstract][Full Text] [Related]
19. Roles of p-ERM and Rho-ROCK signaling in lymphocyte polarity and uropod formation.
Lee JH; Katakai T; Hara T; Gonda H; Sugai M; Shimizu A
J Cell Biol; 2004 Oct; 167(2):327-37. PubMed ID: 15504914
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological properties of Y-27632, a specific inhibitor of rho-associated kinases.
Ishizaki T; Uehata M; Tamechika I; Keel J; Nonomura K; Maekawa M; Narumiya S
Mol Pharmacol; 2000 May; 57(5):976-83. PubMed ID: 10779382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
